LENSAR, based in Orlando, Florida, develops femtosecond laser technology for cataract surgery and went public on September 21, 2020. Its product line includes the LENSAR Laser System and ALLY System, enhancing surgical outcomes.
LNSR has been in the news recently: LENSAR, Inc. will showcase its advanced cataract treatment technologies at the H.C. Wainwright Conference on September 9 and hold one-on-one meetings at the Lake Street Conference on September 12, 2024. Additionally, on September 3, 2024, the company granted stock options for 2,425 shares at $4.63 each to three new employees as part of their employment agreements.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.